Literature DB >> 18209066

differential roles for the E2A activation domains in B lymphocytes and macrophages.

Savita Bhalla1, Christina Spaulding, Rachel L Brumbaugh, Derek E Zagort, Mark E Massari, Cornelis Murre, Barbara L Kee.   

Abstract

The E2A gene encodes two E protein/class I basic helix-loop-helix transcription factors, E12 and E47, that are essential for B lymphopoiesis. In addition to the DNA-binding and protein dimerization domain, the E proteins share two highly conserved transcription activation domains. In this study, we show that both activation domains are required for optimal E2A-dependent transcription. Surprisingly, however, neither activation domain is required for E2A to rescue B lymphopoiesis from E2A(-/-) hemopoietic progenitors, although the N terminus of E2A, which harbors some transcription capacity, is required. Therefore, the E protein activation domains function redundantly in promoting B cell development. In contrast, the N-terminal activation domain, AD1, is required for a newly described ability of E2A to suppress macrophage development in vitro. Our findings demonstrate distinct functionalities for the E protein activation domains in B lymphocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209066     DOI: 10.4049/jimmunol.180.3.1694

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.

Authors:  Chun Guo; Qiande Hu; Chunxia Yan; Jinsong Zhang
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

2.  Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions.

Authors:  Shawn W Cochrane; Ying Zhao; Robert S Welner; Xiao-Hong Sun
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

3.  A TAF4 coactivator function for E proteins that involves enhanced TFIID binding.

Authors:  Wei-Yi Chen; Jinsong Zhang; Huimin Geng; Zhimei Du; Tomoyoshi Nakadai; Robert G Roeder
Journal:  Genes Dev       Date:  2013-07-15       Impact factor: 11.361

Review 4.  B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1.

Authors:  James Hagman; Julita Ramírez; Kara Lukin
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Essential roles of Da transactivation domains in neurogenesis and in E(spl)-mediated repression.

Authors:  Ioanna Zarifi; Marianthi Kiparaki; Konstantinos A Koumbanakis; Nikolaos Giagtzoglou; Evanthia Zacharioudaki; Anastasios Alexiadis; Ioannis Livadaras; Christos Delidakis
Journal:  Mol Cell Biol       Date:  2012-09-04       Impact factor: 4.272

Review 6.  Transcriptional control of early T and B cell developmental choices.

Authors:  Ellen V Rothenberg
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

7.  Mtg16/Eto2 contributes to murine T-cell development.

Authors:  Aubrey Hunt; Melissa Fischer; Michael E Engel; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

8.  MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.

Authors:  Zhihong Yang; Kyle L MacQuarrie; Erwin Analau; Ashlee E Tyler; F Jeffery Dilworth; Yi Cao; Scott J Diede; Stephen J Tapscott
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

9.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

10.  E2A proteins promote development of lymphoid-primed multipotent progenitors.

Authors:  Sheila Dias; Robert Månsson; Sandeep Gurbuxani; Mikael Sigvardsson; Barbara L Kee
Journal:  Immunity       Date:  2008-07-31       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.